Funding Rounds
Accera Series B round
CerecinCerecin, formerly Accera, is a company that looks to develop therapeutic drugs for neurodegenerative diseases.
Summary
Stage: Series B
Raised Amount: $7.50M
Raised Date: 2006-08-16
Stage: Series B
Raised Amount: $7.50M
Raised Date: 2006-08-16